COSBI is a bioinformatics company founded in 2005 and owned 50% by Microsoft Research and 50% by the University of Trento.
Most of the technologies and algorithms we use in providing services to pharma and food companies have been defined and implemented by our experienced team of mathematicians, engineers and physicists. We published benchmarks showing that our technology in biomarker identification, pathway enrichment analysis and dynamic simulation are setting the state of the art.
We started in 1995 developing algorithms and tool for systems biology and we have huge experience in comparing different approaches and selecting the best according to the scientific question to be answered. Additionally, we have lot of experience in working with companies: it is 9 years now that we generate revenues based on our technology.
COSBI collaborate with its customers to perform complex research tasks and complex computational analyses. We usually set up meetings every second week with the customer to align and share the strategic decisions to be made in order to focus on the translational and interesting aspects of the problem at hand. We manipulate and integrate different data types (ranging from all the omics to clinical markers to life-style parameters). COSBI run a pipeline that start from the collection of data exiting the wet lab till the biological interpretation of the analyses performed.
identify biomarkers of treatment response or classification of disease sub-types
predict and quantify the mechanistic effect of treatments and the role of master regulators
Cosbi has not received any reviews.
Cosbi has not received any endorsements.